BioNTech SE (BNTX) Other Non-Current Assets (2018 - 2025)
BioNTech SE (BNTX) reported Other Non-Current Assets of $9.4 million for Q4 2025, down 11.76% on a YoY basis from $10.7 million in Q4 2024, and down 9.38% sequentially from $10.4 million in Q3 2025.
BioNTech SE (BNTX) Other Non-Current Assets (2018 - 2025) Analysis & Trends
BioNTech SE (BNTX) has 7 years of Other Non-Current Assets data on file, last reported at $9.4 million in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets fell 11.76% year-over-year to $9.4 million; the trailing twelve-month figure through Dec 2025 stood at $9.4 million (down 11.76% YoY), and the FY2025 full-year result was $9.2 million, down 14.36% from the prior year.
- Other Non-Current Assets slipped to $9.4 million in Q4 2025, from $10.4 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $302.9 million in Q3 2024 to a low of $4.2 million in Q2 2024.
- A 4-year average of $40.5 million and a median of $9.8 million in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets jumped 10780.43% in 2021 and tumbled 96.56% in 2025, its largest moves.
- Tracing BNTX's Other Non-Current Assets over 4 years: stood at $129.7 million in 2021, then tumbled by 95.94% to $5.3 million in 2023, then soared by 102.69% to $10.7 million in 2024, then slipped by 11.76% to $9.4 million in 2025.
- Business Quant data shows BNTX's Other Non-Current Assets at $9.4 million in Q4 2025, $10.4 million in Q3 2025, and $9.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | BioNTech SE | 22.13 Bn | 22.13 Bn | 668.28 Mn | 9.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.43 Mn |
| Sep 30, 2025 | 10.40 Mn |
| Jun 30, 2025 | 9.85 Mn |
| Mar 31, 2025 | 10.52 Mn |
| Dec 31, 2024 | 10.69 Mn |
| Sep 30, 2024 | 302.89 Mn |
| Jun 30, 2024 | 4.20 Mn |
| Mar 31, 2024 | 13.14 Mn |
| Dec 31, 2023 | 5.27 Mn |
| Sep 30, 2023 | 7.40 Mn |
| Jun 30, 2023 | 6.42 Mn |
| Mar 31, 2023 | 6.12 Mn |
| Dec 31, 2021 | 129.73 Mn |
| Dec 31, 2020 | 1.19 Mn |
| Dec 31, 2019 | 6.49 Mn |
| Sep 30, 2019 | 8.84 Mn |
| Dec 31, 2018 | 2.68 Mn |